Efficacy Of Botulinum Toxin In Patients With Infantile Esotropia: The Long-Term Effect With A Single Injection

2018 ◽  
Author(s):  
Ebru Demet Aygıt
2005 ◽  
Vol 63 (2a) ◽  
pp. 221-224 ◽  
Author(s):  
Laura Silveira-Moriyama ◽  
Lilian R. Gonçalves ◽  
Hsin Fen Chien ◽  
Egberto R. Barbosa

To evaluate the long-term effect of botulinum toxin type A (BTX) in the treatment of blepharospasm, a retrospective analysis was conducted from the patients seen at the Movement Disorders Clinic of the Department of Neurology, Hospital das Clínicas, University of São Paulo School of Medicine from 1993 to 2003. A total of 379 treatments with BTX were administered to 30 patients with blepharospasm. Sixty six per cent of the subjects had used oral medication for dystonia and only 15% of them reported satisfactory response to this treatment. Ninety three per cent of the patients showed significant improvement after the first BTX injection. There was no decrement in response when compared the first and the last injection recorded. Adverse effects, mostly minor, developed at least once in 53% of patients. Six patients (20%) discontinued the treatment but there was no case of secondary resistance.


2008 ◽  
Vol 2 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Aviva Fattal-Valevski ◽  
Dafna Domenievitz ◽  
Nir Giladi ◽  
Shlomo Wientroub ◽  
Shlomo Hayek

Neurology ◽  
1998 ◽  
Vol 50 (5) ◽  
pp. 1461-1463 ◽  
Author(s):  
J.W.M. Brans ◽  
R. Lindeboom ◽  
M. Aramideh ◽  
J. D. Speelman

2006 ◽  
Vol 37 (S 1) ◽  
Author(s):  
A Fattal-Valevski ◽  
S Hayek ◽  
D Domenievitz ◽  
N Giladi ◽  
S Harel ◽  
...  

2017 ◽  
Vol 75 (2) ◽  
pp. 87-91 ◽  
Author(s):  
Jean Pierre Mette Batisti ◽  
Alais Daiane Fadini Kleinfelder ◽  
Natália Bassalobre Galli ◽  
Adriana Moro ◽  
Renato Puppi Munhoz ◽  
...  

ABSTRACT Hemifacial spasm (HFS) is a common movement disorder characterized by involuntary tonic or clonic contractions of the muscles innervated by the facial nerve. Objective To evaluate the long-term effect of botulinum toxin type A (BTX-A) in the treatment of HFS. Methods A retrospective analysis of patients treated at the Movement Disorders Outpatient Clinic in the Neurology Service, Hospital de Clínicas, Federal University of Paraná, Curitiba, from 2009 to 2013 was carried out. A total of 550 BTX-A injections were administered to 100 HFS patients. Results Mean duration of improvement following each injection session was 3.1 months, mean latency to detection of improvement was 7.1 days and mean success rate was 94.7%. Patients were evaluated at an interval of 5.8 months after each application. Adverse effects, which were mostly minor, were observed in 37% of the patients at least once during follow-up. The most frequent was ptosis (35.1%). Conclusion Treatment of HFS with BTX-A was effective, sustainable and safe and had minimal, well-tolerated side effects.


2021 ◽  
Vol 429 ◽  
pp. 117672
Author(s):  
Carlo Alberto Artusi ◽  
Francesco Marchet ◽  
Ugo Dimanico ◽  
Maurizio Zibetti ◽  
Marco Bozzali ◽  
...  

2015 ◽  
Vol 45 (1) ◽  
pp. 9-13
Author(s):  
Mehmet Orçun Akdemir ◽  
Sılay Cantürk Uğurbaş ◽  
Suat Hayri Uğurbaş

Sign in / Sign up

Export Citation Format

Share Document